Logo image of MOTS

MOTUS GI HOLDINGS INC (MOTS) Stock Fundamental Analysis

NASDAQ:MOTS - Nasdaq - US62014P5044 - Common Stock - Currency: USD

0.1735  -0.09 (-34.06%)

After market: 0.1512 -0.02 (-12.85%)

Fundamental Rating

2

MOTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. MOTS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MOTS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MOTS had negative earnings in the past year.
In the past year MOTS has reported a negative cash flow from operations.
In the past 5 years MOTS always reported negative net income.
MOTS had a negative operating cash flow in each of the past 5 years.
MOTS Yearly Net Income VS EBIT VS OCF VS FCFMOTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

MOTS has a worse Return On Assets (-178.25%) than 92.31% of its industry peers.
With a Return On Equity value of -479.16%, MOTS is not doing good in the industry: 88.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -178.25%
ROE -479.16%
ROIC N/A
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
MOTS Yearly ROA, ROE, ROICMOTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MOTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MOTS Yearly Profit, Operating, Gross MarginsMOTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K -50K

More info and screens

2

2. Health

2.1 Basic Checks

MOTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
MOTS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MOTS has been increased compared to 5 years ago.
MOTS has a better debt/assets ratio than last year.
MOTS Yearly Shares OutstandingMOTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
MOTS Yearly Total Debt VS Total AssetsMOTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

MOTS has an Altman-Z score of -34.76. This is a bad value and indicates that MOTS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -34.76, MOTS is doing worse than 91.79% of the companies in the same industry.
A Debt/Equity ratio of 0.46 indicates that MOTS is not too dependend on debt financing.
MOTS has a worse Debt to Equity ratio (0.46) than 62.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -34.76
ROIC/WACCN/A
WACC10.68%
MOTS Yearly LT Debt VS Equity VS FCFMOTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 1.76 indicates that MOTS should not have too much problems paying its short term obligations.
MOTS has a worse Current ratio (1.76) than 77.44% of its industry peers.
MOTS has a Quick Ratio of 1.61. This is a normal value and indicates that MOTS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MOTS (1.61) is worse than 67.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.61
MOTS Yearly Current Assets VS Current LiabilitesMOTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

MOTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.99%, which is quite impressive.
MOTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -46.00%.
MOTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.48% yearly.
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.19%
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Sales Q2Q%-41.82%

3.2 Future

The Earnings Per Share is expected to grow by 25.56% on average over the next years. This is a very strong growth
MOTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 206.79% yearly.
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MOTS Yearly Revenue VS EstimatesMOTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
MOTS Yearly EPS VS EstimatesMOTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MOTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MOTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOTS Price Earnings VS Forward Price EarningsMOTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MOTS Per share dataMOTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

A more expensive valuation may be justified as MOTS's earnings are expected to grow with 25.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.28%
EPS Next 3Y25.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MOTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOTUS GI HOLDINGS INC

NASDAQ:MOTS (4/15/2024, 8:19:47 PM)

After market: 0.1512 -0.02 (-12.85%)

0.1735

-0.09 (-34.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-18 2024-03-18/amc
Earnings (Next)05-08 2024-05-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners134.91%
Ins Owner Change0%
Market Cap872.70K
Analysts82.86
Price Target8.47 (4781.84%)
Short Float %0.12%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)22.83%
Min EPS beat(2)-4.82%
Max EPS beat(2)50.49%
EPS beat(4)3
Avg EPS beat(4)21.64%
Min EPS beat(4)-4.82%
Max EPS beat(4)50.49%
EPS beat(8)7
Avg EPS beat(8)19.82%
EPS beat(12)10
Avg EPS beat(12)16.65%
EPS beat(16)12
Avg EPS beat(16)14.53%
Revenue beat(2)0
Avg Revenue beat(2)-45.1%
Min Revenue beat(2)-68.63%
Max Revenue beat(2)-21.57%
Revenue beat(4)0
Avg Revenue beat(4)-52.61%
Min Revenue beat(4)-90.59%
Max Revenue beat(4)-21.57%
Revenue beat(8)0
Avg Revenue beat(8)-47.11%
Revenue beat(12)3
Avg Revenue beat(12)-20.84%
Revenue beat(16)4
Avg Revenue beat(16)-26.2%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.61%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.69
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-28.56
EYN/A
EPS(NY)-11.9
Fwd EYN/A
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS0.06
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -178.25%
ROE -479.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 23.06%
Cap/Sales 32.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.61
Altman-Z -34.76
F-Score3
WACC10.68%
ROIC/WACCN/A
Cap/Depr(3y)57.67%
Cap/Depr(5y)82.07%
Cap/Sales(3y)63.47%
Cap/Sales(5y)141.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.19%
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Sales Q2Q%-41.82%
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A
EBIT growth 1Y33.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.92%
OCF growth 3YN/A
OCF growth 5YN/A